BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:03 AM UTC
BusinessProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 PatientsBy Nasdaq OMXApr 27, 2017, 11:02 AM UTC